Article Information
History
- June 20, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- aSchool of Computing, Queen’s University, Kingston, Ontario, Canada, K7L 3N6
- bDepartment of Molecular and Biomedical Sciences, Queen’s University, Kingston, Ontario, Canada, K7L 3N6
- cDivision of Gastroenterology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1
- dDepartment of Biological Sciences, Faculty of Science, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1
- ↵*Shared corresponding author E-mails: amber.simpson{at}queensu.ca, gane{at}ualberta.ca.
Posted June 20, 2024.
Minimizing biological risk for novel inhibitory drug targets: One knockout is all you need
